The settlement between 3M and a Chubb unit resolves a dispute over insurance coverage for litigation tied to the Bair Hugger surgical warming device. It doesn’t resolve the underlying product cases, where thousands of claims remain pending. As of July 1, 8,411 cases were pending in Minnesota federal court, making the docket the nation’s sixth-largest multidistrict litigation, according to the U.S. Judicial Panel on Multidistrict Litigation.
The court dismissed Federal Insurance Co. v. 3M Co. on Monday after the parties reached a confidential settlement. The amount and terms aren’t public in the supplied account, so the settlement can’t be read as a measure of either side’s view of the underlying claims. Plaintiffs in the wider litigation allege that the forced-air warming blanket, which helps maintain patients’ body temperature during surgery, can cause bacterial infections. Those allegations remain allegations; the coverage case addressed how insurance obligations applied to the defense of the litigation, not whether the device caused injuries.
That distinction matters for anyone tracking the business consequences. An insurance dispute can determine who bears some of the cost of responding to claims, while leaving questions about product liability and the merits of individual cases unresolved. The dismissal closes one legal track. It doesn’t tell readers how the remaining cases will end, or how much their defense may ultimately cost.
What the coverage rulings established
Federal Insurance sued in 2021, arguing that each surgery represented a separate occurrence under its policy and triggered an individual deductible. That position would have treated the claims as numerous separate events for purposes of the policy. 3M, by contrast, benefited from the court’s conclusion that the device’s design and manufacture constituted a single occurrence. In November 2022, a federal court in Minneapolis ruled that 3M was responsible for one deductible.
The ruling gave the parties a framework for allocating insurance costs, but it didn’t settle every question about who would pay for the broader litigation. The court also ruled that Federal Insurance was responsible only for defense costs tied to cases covered by its policies, rather than the full cost of defending the multidistrict litigation. In a large consolidated docket, that distinction can be consequential: one insurer’s obligations may apply to only part of the claims or only certain periods of coverage, depending on the policy and the cases at issue.
Those are familiar pressure points in insurance disputes connected to mass litigation. The underlying claims may be grouped together for court management, but policy language can require a separate analysis of what counts as an occurrence and which claims fall within coverage. The ruling addressed those issues as presented in this case; it shouldn’t be treated as a general answer for other policies or disputes.
The parties had paused the coverage case while the underlying litigation proceeded. That pause left the coverage questions open while the larger docket continued, and the confidential settlement now ends the dispute between these parties without disclosing how they resolved the financial terms. The public record described here establishes the dismissal and the prior rulings, but it doesn’t reveal whether the settlement changed the practical allocation set by the court.
Underlying cases remain unresolved
Formed in 2015, the Minnesota docket has no global settlement. The Bair Hugger remains widely used; Solventum, the 3M spinoff that makes the device, says studies have found it safe and effective. That statement reflects the company’s position, while plaintiffs’ allegations reflect the claims they’re pursuing. The two shouldn’t be collapsed into a conclusion about the device’s safety or about the outcome of the pending cases.
The scale of the docket is significant, but the case count alone doesn’t show how many claims will proceed to resolution, what evidence will be presented, or what financial consequences may follow. Multidistrict litigation centralizes related cases for coordinated pretrial handling; it doesn’t automatically produce a single outcome for every plaintiff. Different claims can involve different facts, and a lack of global settlement means the broader dispute remains active.
This is more significant than it looks: the settlement removes a dispute over insurance responsibility while the underlying litigation continues to create uncertainty for the companies connected to the device. The insurance case could affect who pays some defense costs, but its dismissal doesn’t reduce the reported number of pending cases or settle the allegations themselves. And this is the part most people overlook: ending a coverage fight can simplify one part of a company’s exposure without making the product litigation disappear.
What the settlement changes—and what it doesn’t
For 3M and the Chubb unit, the immediate change is procedural: the court has dismissed their coverage case after a confidential settlement. The earlier rulings remain part of the history explaining the dispute, but the settlement’s undisclosed terms leave outsiders unable to determine whether either party paid, received, or otherwise agreed to a particular allocation. No more can be inferred from the dismissal alone.
For observers of the underlying litigation, the clearer signal is continuity. Thousands of cases were still pending as of the reported date, and the docket had no global settlement. The coverage resolution may remove one source of friction over defense costs, yet it doesn’t establish a timetable or outcome for those cases. The source provides no basis for predicting either.
If you're working in this space, keep the two tracks separate when describing the exposure: the insurance dispute concerned policy coverage and defense costs, while the underlying cases concern alleged infections associated with the device. Here's the thing: a confidential settlement can close a case while leaving the most visible questions unanswered. The coverage case is over. The larger litigation isn’t.